Perfil de seguridad de Alpinia calcarata Roscoe usada en medicina tradicional en Sri Lanka

El objetivo del presente estudio fue investigar si los rizomas de Alpinia calcarata Roscoe (Familia: Zingiberaceae) tienen algún efecto tóxico en las ratas. Se utilizaron ratas Wistar como modelo experimental y administrado por vía oral de extracto de agua caliente (EAC) y el extracto de etanol caliente (EEC) de A. rizomas calcarata a una dosis de 1500 mg / kg, respectivamente, durante 42 días consecutivos. La administración de la EAC o EEC a las ratas no produjo ningún efecto crónico tóxico como se desprende de sus efectos sobre la (a) función hepática (b) la función renal, (c) los parámetros hematológicos, como conteo de los glóbulos rojos (GR), conteo de glóbulos blancos celular (GB) y hemoglobina (Hb), (d) morfología externa y el peso húmedo de los órganos seleccionados. Además, el EAC y el EEC no parecen mediar efectos inaceptables en la ingesta de alimentos y agua, porcentaje de aumento de peso, la consistencia de las heces y el color de la orina. En conclusión, los resultados de este estudio han revelado que los extractos EAC y la EEC de A. calcarata en las dosis utilizadas no producen graves efectos secundarios tóxicos en ratas

Antidiabetic activity of Trichosanthes cucumerina in normal and streptozotocin–induced diabetic rats

Aerial parts of Trichosanthes cucumerina (Family: Cucurbitaceae) are used in traditional medical systems for treatment of diabetes and other diseases. The present study was designed to experimentally evaluate the antidiabetic potential of a hot water extract (HWE) of T. cucumerina (TC) aerial parts. In normoglycemic rats, HWE mediated (a) a dose dependent reduction in fasting blood glucose (FBS) levels (by 35% at 4h post-treatment with dose of 750 mg/kg) and (b) a significant (

FLUORINATED ARENE, IMIDE AND UNSATURATED PYRROLIDINONE BASED DONOR ACCEPTOR CONJUGATED POLYMERS: SYNTHESIS, STRUCTURE-PROPERTY AND DEVICE STUDIES

FLUORINATED ARENE, IMIDE AND LACTAM-FUNCTIONALIZED DONOR ACCEPTOR CONJUGATED POLYMERS: SYNTHESIS, STRUCTURE-PROPERTY AND DEVICE STUDIES After the discovery of doped polyacetylene, organic semiconductor materials are widely studied as high impending active components in consumer electronics. They have received substantial consideration due to their potential for structural tailoring, low cost, large area and mechanically flexible alternatives to common inorganic semiconductors. To acquire maximum use of these materials, it is essential to get a strong idea about their chemical and physical nature. Material chemist has an enormous role to play in this novel area, including development of efficient synthetic methodologies and control the molecular self-assembly and (opto)-electronic properties. The body of this thesis mainly focuses on the substituent effects: how different substituent’s affect the (opto)-electronic properties of the donor-acceptor (D-A) conjugated polymers. The main priority goes to understand, how different alkyl substituent effect to the polymer solubility, crystallinity, thermal properties (eg: glass transition temperature) and morphological order. Three classes of D-A systems were extensively studied in this work. The second chapter mainly focuses on the synthesis and structure-property study of fluorinated arene (TFB) base polymers. Here we used commercially available 1,4-dibromo-2,3,5,6-tetrafluorobenzene (TFB) as the acceptor material and prepare several polymers using 3,3’-dialkyl(3,3’-R2T2) or 3,3’-dialkoxy bithiophene (3,3’-RO2T2) units as electron donors. A detail study was done using 3,3’-bithiophene donor units incorporating branched alkoxy-functionalities by systematic variation of branching position and chain length. The study allowed disentangling the branching effects on (i) aggregation tendency, intermolecular arrangement, (iii) solid state optical energy gaps, and (iv) electronic properties in an overall consistent picture, which might guide future polymer synthesis towards optimized materials for opto-electronic applications. The third chapter mainly focused on the structure-property study of imide functionalized D-A polymers. Here we used thiophene-imide (TPD) as the acceptor moiety and prepare several D-A polymers by varying the donor units. When selecting the donor units, more priority goes to the fused ring systems. One main reason to use imide functionality is due to the, open position of the imide nitrogen, which provides an attaching position to alkyl substituent. Through this we can easily manipulate solubility and solid state packing arrangement. Also these imide acceptors have low-lying LUMOs due to their electron deficient nature and this will allow tuning the optical energy gap by careful choice of donor materials with different electron donating ability. The fourth chapter mainly contribute to the synthesis and structure property study of a completely novel electron acceptor moiety consist of a unsaturated pyrrolidinone unit known as Pechmann dye (PD) core. Pechmann dyes are closely related to the Indigo family. This can refer as 3-butenolide dimer connected via an alkene bridge, containing a benzene ring at the 5 and 5’ positions of the lactone rings. We have prepared several D-A polymers using this PD system with benzodithiophene (BDT) as the donor unit. Different to common D-A polymers the HOMO and LUMO of the PD acceptor moiety are energetically located within the gap of the BDT, so that the electronic and optical properties (HOMO-LUMO transition) are dictated by the PD properties. The promising electronic properties, band gaps, high absorption coefficients and broad absorption suggest this new D-A polymers as an interesting donor material for organic solar cell (OSC) applications

Chemical Analysis: A Common Medicated Oil Base use in Ayurveda

Medicated oil preparation process is named as Sneha Kalpana in Ayurveda and they are used to treat wide range of diseases. Medicated oils are prepared by prolonged cooking with coconut/ king coconut oil, sesame oil, different crude oils like castor oil, mustard oil, ghee and substances like,nbspKalkanbsp(herbal paste prepared by different parts of botanicals),nbspKvathanbsp(specifically prepared decoction in accordance of Ayurvedic principles) ornbspDrava Dravyanbsp(any other liquid such as milk, self-expressed juices, etc.). A considerable amount of sesame oil and ghee is present in many medicated oils such as Dashamooladi Ghrita, Chitrakadi Ghrita, Baladi Ghrita, Nirghundi Taila, Ashwandha Ghrita, Vipadikahara Ghrita, Moolaka Taila, Sacharadi Taila, Swandranstha Taila and Rasna Taila. Therefore, it is very important to assess the quality of the base consist of sesame oil and ghee. The objective of the present study was to evaluate the quality in terms of specific gravity, refractive index, acid value, saponification value and development of TLC profile of the base consists of sesame oil and ghee in a ratio of 1:1 w/w by using standard protocols. Results revealed that specific gravity, acid value, saponification value, peroxide value and iodine value were 0.91plusmn 0.00, 2.00 plusmn 0.06 KOH/g, 431.57 plusmn 1.43 mg/g, 1.33 plusmn 0.06 Meq/kg and 56plusmn1.04 g I2/100g respectively. TLC fingerprint profiles were developed using 3 solvent systems. In conclusion, present study will help to establish quality control parameters of base of medicated oils which consist of sesame oil and ghee in a ratio of 1:1 w/w

Evaluation of the toxic potential of standardized extracts (hot water extract and cold ethanolic extract) of Trichosanthes cucumerina Linn. aerial parts

Trichosanthes cucumerina Linn. Es una de las plantas comunmente utilizadas en el sistema de medicina tradicional de Sri Lanka, en la preparación de formulaciones para el tratamiento de diversas enfermedades. Debido a que los efectos tóxicos de T. cucumerina no se conocen, los objetivos de este estudio fueron: (a) estandarizar los extractos obtenidos con agua caliente (EAC) y con etanol frío (EEF), y (b) evaluar la toxicidad de ambos extractos. Ambos extractos fueron estandarizados por obtención de sus densitogramas y huella digital con HPLC. Adicionalmente se determinaron parámetros fisicoquímicos, tales como: cenizas totales, cenizas solubles en agua y cenizas solubles en ácido. La administración de EAC y EEF a ratones no mostró efectos tóxicos agudos ni crónicos. Las funciones renales, hepáticas, estudios hematológicos y de fertilidad en machos y hembras fueron normales. Se concluye que los extractos estandarizados de T. cucumerina, a las dosis ensayadas no producen ningún efecto tóxico.Trichosanthes cucumerina Linn. is one of the medicinal plants that is often used in Sri Lankan traditional systems of medicine for the preparation of formulations to treat a variety of disease conditions. However, the toxic effects of T. cucumerina are not known. The aims of the present study were to (a) standardize hot water (HWE) and cold ethanolic (CEE) extracts of T. cucumerina aerial parts, and (b) evaluate toxic potential of the plant extracts. Both extracts were standardized by developing their densitograms and HPLC fingerprints and determination of physico – chemical parameters such as total ash, water soluble ash and acid insoluble ash. Administration of the HWE or CEE to mice did not result in acute or chronic toxic effects as evident from their effects on (a) liver and kidney functions and (c) hematological parameters and (d) fertility of male or female mice.In conclusion, the results of this study have revealed that standardized extracts of T. cucumerina at the doses tested do not produce any serious toxic side effects

Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation

Background: Mechanical chest compression devices may help to maintain high-quality cardiopulmonary resuscitation (CPR), but little evidence exists for their effectiveness. We evaluated whether or not the introduction of Lund University Cardiopulmonary Assistance System-2 (LUCAS-2; Jolife AB, Lund, Sweden) mechanical CPR into front-line emergency response vehicles would improve survival from out-of-hospital cardiac arrest (OHCA). Objective: Evaluation of the LUCAS-2 device as a routine ambulance service treatment for OHCA. Design: Pragmatic, cluster randomised trial including adults with non-traumatic OHCA. Ambulance dispatch staff and those collecting the primary outcome were blind to treatment allocation. Blinding of the ambulance staff who delivered the interventions and reported initial response to treatment was not possible. We also conducted a health economic evaluation and a systematic review of all trials of out-of-hospital mechanical chest compression. Setting: Four UK ambulance services (West Midlands, North East England, Wales and South Central), comprising 91 urban and semiurban ambulance stations. Clusters were ambulance service vehicles, which were randomly assigned (approximately 1 : 2) to the LUCAS-2 device or manual CPR. Participants: Patients were included if they were in cardiac arrest in the out-of-hospital environment. Exclusions were patients with cardiac arrest as a result of trauma, with known or clinically apparent pregnancy, or aged < 18 years. Interventions: Patients received LUCAS-2 mechanical chest compression or manual chest compressions according to the first trial vehicle to arrive on scene. Main outcome measures: Survival at 30 days following cardiac arrest; survival without significant neurological impairment [Cerebral Performance Category (CPC) score of 1 or 2]. Results: We enrolled 4471 eligible patients (1652 assigned to the LUCAS-2 device and 2819 assigned to control) between 15 April 2010 and 10 June 2013. A total of 985 (60%) patients in the LUCAS-2 group received mechanical chest compression and 11 (< 1%) patients in the control group received LUCAS-2. In the intention-to-treat analysis, 30-day survival was similar in the LUCAS-2 (104/1652, 6.3%) and manual CPR groups [193/2819, 6.8%; adjusted odds ratio (OR) 0.86, 95% confidence interval (CI) 0.64 to 1.15]. Survival with a CPC score of 1 or 2 may have been worse in the LUCAS-2 group (adjusted OR 0.72, 95% CI 0.52 to 0.99). No serious adverse events were noted. The systematic review found no evidence of a survival advantage if mechanical chest compression was used. The health economic analysis showed that LUCAS-2 was dominated by manual chest compression. Limitations: There was substantial non-compliance in the LUCAS-2 arm. For 272 out of 1652 patients (16.5%), mechanical chest compression was not used for reasons that would not occur in clinical practice. We addressed this issue by using complier average causal effect analyses. We attempted to measure CPR quality during the resuscitation attempts of trial participants, but were unable to do so. Conclusions: There was no evidence of improvement in 30-day survival with LUCAS-2 compared with manual compressions. Our systematic review of recent randomised trials did not suggest that survival or survival without significant disability may be improved by the use of mechanical chest compression. Future work: The use of mechanical chest compression for in-hospital cardiac arrest, and in specific circumstances (e.g. transport), has not yet been evaluated

An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression

Dysregulated host responses to infection can lead to organ dysfunction and sepsis, causing millions of global deaths each year. To alleviate this burden, improved prognostication and biomarkers of response are urgently needed. We investigated the use of whole-blood transcriptomics for stratification of patients with severe infection by integrating data from 3149 samples from patients with sepsis due to community-acquired pneumonia or fecal peritonitis admitted to intensive care and healthy individuals into a gene expression reference map. We used this map to derive a quantitative sepsis response signature (SRSq) score reflective of immune dysfunction and predictive of clinical outcomes, which can be estimated using a 7- or 12-gene signature. Last, we built a machine learning framework, SepstratifieR, to deploy SRSq in adult and pediatric bacterial and viral sepsis, H1N1 influenza, and COVID-19, demonstrating clinically relevant stratification across diseases and revealing some of the physiological alterations linking immune dysregulation to mortality. Our method enables early identification of individuals with dysfunctional immune profiles, bringing us closer to precision medicine in infection

An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression.

Dysregulated host responses to infection can lead to organ dysfunction and sepsis, causing millions of global deaths each year. To alleviate this burden, improved prognostication and biomarkers of response are urgently needed. We investigated the use of whole-blood transcriptomics for stratification of patients with severe infection by integrating data from 3149 samples from patients with sepsis due to community-acquired pneumonia or fecal peritonitis admitted to intensive care and healthy individuals into a gene expression reference map. We used this map to derive a quantitative sepsis response signature (SRSq) score reflective of immune dysfunction and predictive of clinical outcomes, which can be estimated using a 7- or 12-gene signature. Last, we built a machine learning framework, SepstratifieR, to deploy SRSq in adult and pediatric bacterial and viral sepsis, H1N1 influenza, and COVID-19, demonstrating clinically relevant stratification across diseases and revealing some of the physiological alterations linking immune dysregulation to mortality. Our method enables early identification of individuals with dysfunctional immune profiles, bringing us closer to precision medicine in infection

Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries.

BACKGROUND: As global initiatives increase patient access to surgical treatments, there remains a need to understand the adverse effects of surgery and define appropriate levels of perioperative care. METHODS: We designed a prospective international 7-day cohort study of outcomes following elective adult inpatient surgery in 27 countries. The primary outcome was in-hospital complications. Secondary outcomes were death following a complication (failure to rescue) and death in hospital. Process measures were admission to critical care immediately after surgery or to treat a complication and duration of hospital stay. A single definition of critical care was used for all countries. RESULTS: A total of 474 hospitals in 19 high-, 7 middle- and 1 low-income country were included in the primary analysis. Data included 44 814 patients with a median hospital stay of 4 (range 2-7) days. A total of 7508 patients (16.8%) developed one or more postoperative complication and 207 died (0.5%). The overall mortality among patients who developed complications was 2.8%. Mortality following complications ranged from 2.4% for pulmonary embolism to 43.9% for cardiac arrest. A total of 4360 (9.7%) patients were admitted to a critical care unit as routine immediately after surgery, of whom 2198 (50.4%) developed a complication, with 105 (2.4%) deaths. A total of 1233 patients (16.4%) were admitted to a critical care unit to treat complications, with 119 (9.7%) deaths. Despite lower baseline risk, outcomes were similar in low- and middle-income compared with high-income countries. CONCLUSIONS: Poor patient outcomes are common after inpatient surgery. Global initiatives to increase access to surgical treatments should also address the need for safe perioperative care. STUDY REGISTRATION: ISRCTN5181700

An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression

Dysregulated host responses to infection can lead to organ dysfunction and sepsis, causing millions of global deaths each year. To alleviate this burden, improved prognostication and biomarkers of response are urgently needed. We investigated the use of whole-blood transcriptomics for stratification of patients with severe infection by integrating data from 3149 samples from patients with sepsis due to community-acquired pneumonia or fecal peritonitis admitted to intensive care and healthy individuals into a gene expression reference map. We used this map to derive a quantitative sepsis response signature (SRSq) score reflective of immune dysfunction and predictive of clinical outcomes, which can be estimated using a 7- or 12-gene signature. Last, we built a machine learning framework, SepstratifieR, to deploy SRSq in adult and pediatric bacterial and viral sepsis, H1N1 influenza, and COVID-19, demonstrating clinically relevant stratification across diseases and revealing some of the physiological alterations linking immune dysregulation to mortality. Our method enables early identification of individuals with dysfunctional immune profiles, bringing us closer to precision medicine in infection.peer-reviewe